NextGenRnD develops early-stage applied R&D solutions for organizations working on complex scientific and technological challenges.
Our ready-made solutions are designed to help R&D teams move from basic research toward applied proof-of-concept. They combine scientific reasoning, patent and non-patent knowledge, evidence analysis, and experimental planning into structured R&D solution reports.
Each ready-made solution is intended to support the transition from TRL 2 to TRL 3 — from a formulated technology concept toward experimental proof-of-concept (TRL-scale). This reflects the current positioning of NextGenRnD ready-made solutions as concepts enabling the transition from Basic Research to Applied Research.
What is a NextGenRnD Ready-Made Solution?
NextGenRnD ready-made solution is an early-stage applied R&D concept created to address a specific scientific, technological, or industrial problem.
Each solution typically includes:
✓ a formulated technology concept;
✓ a scientific rationale;
✓ a proposed experimental approach;
✓ key assumptions and limitations;
✓ a validation plan;
✓ suggested next steps for advancing the concept toward proof-of-concept.
What You Receive
When you purchase a NextGenRnD ready-made solution, you receive a structured R&D solution report designed for internal R&D evaluation, planning, and execution.
The report may include:
✓ executive summary
✓ R&D problem definition
✓ Technology concept
✓ Scientific and technical rationale
✓ Proposed mechanism or technical approach
✓ Experimental design for proof-of-concept validation
✓ Key assumptions and limitations
The purpose of the report is to help your team understand whether the proposed concept is technically feasible, how it could be tested, and what should be validated next.
What This Is — and What This Is Not
What This Is
A ready-made NextGenRnD solution is:
✓ an early-stage applied R&D concept;
✓ a structured R&D solution report;
✓ a tool for feasibility assessment and experimental planning;
✓ a starting point for proof-of-concept validation.
What This Is Not
A ready-made NextGenRnD solution is not:
✗ a finished product;
✗ a validated prototype;
✗ a guarantee of technical success;
✗ a regulatory opinion;
✗ a patentability opinion;
✗ a freedom-to-operate opinion;
✗ a replacement for customer-specific legal, regulatory, IP.
Unless explicitly stated, ready-made solutions have not yet been reduced to practice by NextGenRnD.
License Summary
Purchasing a ready-made NextGenRnD solution gives the customer a commercial non-exclusive license to use the purchased solution report and the information contained in it under the applicable Terms of Use.
In plain language:
• You may use the purchased solution for internal R&D, evaluation, experimental development and commercial purposes.
• The purchase does not transfer ownership of NextGenRnD intellectual property.
• The same or similar solution may also be licensed to other customers unless exclusivity is available and agreed separately in writing.
• Exclusive rights, field-specific rights, sublicensing rights, custom development, or implementation support may require a separate written agreement.
How Purchase and Delivery Work
1. Review the solution summary and license summary.
2. If needed, contact NextGenRnD before purchase to confirm whether the solution fits your technical need.
3. Complete payment securely through FastSpring.
4. Receive access to the purchased R&D solution report (PDF file) and additional files (if applicable).
5. Use the report under the applicable non-exclusive license terms.
6. Contact NextGenRnD for follow-up consulting, custom validation planning, exclusive licensing, or custom-built solution development.
Before You Buy
Please consider the following before purchasing a ready-made NextGenRnD solution:
• The solution is early-stage and intended for R&D planning and validation design.
• Additional experiments are required to confirm feasibility.
• The solution may not be suitable for every technical environment or customer-specific use case.
• The purchase does not automatically include consulting support unless explicitly stated.
• The purchase does not include legal, regulatory, patentability, or freedom-to-operate advice unless separately agreed.
• If you are unsure whether the solution fits your needs, please contact us before purchase.
Refund and Suitability
! Ready-made NextGenRnD solutions are digital knowledge products. Once the full report has been delivered or accessed, refund eligibility may be limited.
! If you are uncertain whether a specific solution is suitable for your technical need, we recommend contacting NextGenRnD before purchase.
! Refund requests, where applicable, are handled according to the applicable Terms of Use, purchase terms, and the payment provider’s buyer-support process.
Who Should Buy a Ready-Made NextGenRnD Solution?
Ready-made solutions are intended for organizations that need structured early-stage R&D concepts and validation plans.
They may be suitable for:
• corporate R&D teams;
• biotechnology and pharmaceutical companies;
• industrial chemistry and materials companies;
• food, agriculture, animal health, and life-science organizations;
• open innovation and technology scouting teams;
• university spin-offs and deep-tech SMEs;
• grant applicants preparing applied research projects;
• organizations seeking new technical approaches to unresolved R&D problems.
Effective June 27, 2026: Commercial non-exclusive licenses to use the following NextGenRnD solutions are available:
| Solution | Fee | Labels | ||
| Airway smooth muscle spheroid contraction sensor platform | $10000 |
Human Health, Microtissue, Microfluidics, Microscopy, High-Throughput Screening, Molecular Biology, Chemistry, Physics, Mathematics, Design, Engineering
|
||
| Longitudinal detection and quantification of intrathecally-injected antisense oligonucleotides in brain using intravenously delivered probe | $5000 |
ASO detection and quantification in CNS, Design, Engineering, Chemical Biology, Human Health
|
||
| Next generation muscle targeting platform | $5000 |
Antibody Engineering, Phage Display, Targeting Moiety Minimization, Rational Design, Disease Model, Human Health
|
||
| Novel quantitative, robust and high-throughput assay for monitoring tau protein aggregation | $5000 |
Protein Engineering, Biophysics, High-Throughput Screening, Alzheimer's Disease, Tauopathies, Human Health
|
||
| A formulation for improved oral GLP-1 agonist and GLP-1/GIP co-agonist peptide drug delivery | $5000 |
Human Health, Type 2 diabetes, Weight loss, Chronic weight management, Obesity, Therapeutic peptide delivery, Peptide, Design, Engineering
|
||
| Moiety-X-radioligand-targeted “Motif-Y”-tagged therapeutic radiopeptide platform | $5000 |
Human Health, Cancer therapy, Low molecular weight radioligands, Therapeutic peptide platform, Peptide, Peptidomimetic, Lutetium-177, High Tumor to Kidney uptake ratio, Design, Engineering
|
||
| Next Generation Controlled Release Fertilizer (NextGenCRF) | $5000 |
Controlled Release Fertilizer, Biodegradable, Engineering
|
||
| Universal Pipeline for the Extraction of Nucleic Acids, Polysaccharides, and Proteins from Spent Microbial Biomass | $5000 |
Fermentation waste, Spent Microbial Biomass, Valorization, Extraction, Nucleic Acids, Proteins, Polysaccharides, Process Engineering, Aquaculture Health, Animal Health, Human Health
|
||
| RNA Interference Aided Long-Term Culture of Dirofilaria immitis Third Stage Larvae | $5000 |
Dog, Heartworm, Dirofilaria immitis, L3 stage, Culturing, Prevention and Control, Rational Design, One Health
|
||
| Lawsonia intracellularis propagation – a large-scale intracellular pathogen cultivation model | $5000 |
Swine, Lawsonia intracellularis, Cultivation, Attenuation, Vaccine, Enteropathy/Ileitis, Prevention and Control, Rational Design, One Health
|
||
| Systemic therapeutic peptide delivery via gastrointestinal tract | $3000 |
Protein Engineering, Gastrointestinal-to-Systemic Delivery, Rational Design, Human Health
|
||
| Novel drug targets for tuberculosis therapy | $2000 |
Human Health, Animal Health, Microbiology, Evolutionary Biology, Systems Biology
|
||
| Gene therapy targeting platform | $1500 |
Molecular Virology, Gene Therapy, Antibody Engineering, Nanoparticle Targeting, Human Health
|
||
| Galvanized virus – determine the lipid composition of every virion in a virus sample population | $1500 |
Galvanized Virus, Design, Engineering
|
||
| Protection of thermally sensitive proteins added to poultry and swine feed | $1500 |
Animal Feed, Swine, Poultry, Fluidized bed spraying, Encapsulation, Release, One Health
|
||
| Rapid internalizing antibody identification platform | $1000 |
Phage display, Virology, Cell biology, Design, Engineering
|
||
| The Entrepreneur’s Guide to the Programme for Applied Research — Exploiting Patent Information to Boost Return on Investment from Research & Development Projects | $99 |
Analysis report, Programme for Applied Research, The RUP, Rounds I–VI, Rakendusuuringute programm, Voorud I–VI
|
||
Thank you for your proposal which has been selected as the best one. The solution proposed will cover and is compatible with all small antibody formats with no anticipated impact on the antigen-binding site.
The solution is very effective under laboratory conditions.
We were impressed by the description of the in vitro model and the level of detail provided, including the research plan as well as the underlying expertise.
The solution was detailed in the process, modeling and principles of attenuation.
The solution is very complete and innovative.
The solution was extremely detailed and well planned.